HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Jian Ding Selected Research

probimane (AT 2153)

12/2004Antitumor effects of two bisdioxopiperazines against two experimental lung cancer models in vivo.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Jian Ding Research Topics

Disease

219Neoplasms (Cancer)
11/2022 - 12/2002
43Breast Neoplasms (Breast Cancer)
01/2022 - 07/2004
37Neoplasm Metastasis (Metastasis)
01/2022 - 07/2004
19Leukemia
01/2022 - 12/2002
16Carcinoma (Carcinomatosis)
08/2016 - 07/2003
15Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
12/2022 - 09/2006
12Carcinogenesis
12/2021 - 08/2005
11Necrosis
01/2022 - 09/2009
11Hepatocellular Carcinoma (Hepatoma)
01/2021 - 07/2004
11Stomach Neoplasms (Stomach Cancer)
01/2021 - 01/2008
10Colonic Neoplasms (Colon Cancer)
04/2021 - 04/2005
10Infections
01/2016 - 03/2002
9Hypoxia (Hypoxemia)
01/2020 - 12/2004
8Parkinson Disease (Parkinson's Disease)
05/2022 - 08/2015
8Lung Neoplasms (Lung Cancer)
02/2020 - 06/2005
7Inflammation (Inflammations)
01/2022 - 11/2011
7Body Weight (Weight, Body)
04/2020 - 10/2011
7Colorectal Neoplasms (Colorectal Cancer)
01/2020 - 04/2005
7Ovarian Neoplasms (Ovarian Cancer)
01/2019 - 08/2004
6Ischemia
06/2021 - 05/2015
6Edema (Dropsy)
01/2021 - 01/2018
6Brain Ischemia (Cerebral Ischemia)
11/2019 - 02/2014
6HIV Infections (HIV Infection)
01/2018 - 03/2010
5Wounds and Injuries (Trauma)
01/2021 - 02/2008
5Acquired Immunodeficiency Syndrome (AIDS)
01/2018 - 08/2004
5Ataxia Telangiectasia (Louis Bar Syndrome)
01/2012 - 02/2007
4Esophageal Squamous Cell Carcinoma
01/2022 - 10/2019
4Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
01/2021 - 12/2019
4Cardiovascular Diseases (Cardiovascular Disease)
01/2021 - 11/2017
4Hypersensitivity (Allergy)
01/2020 - 05/2005
4Adenocarcinoma
01/2018 - 06/2005
4Adenocarcinoma of Lung
01/2018 - 07/2004
4B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
01/2017 - 07/2015
4Prostatic Neoplasms (Prostate Cancer)
03/2016 - 01/2013
4Sexually Transmitted Diseases (Sexually Transmitted Disease)
09/2013 - 03/2010
4Virus Diseases (Viral Diseases)
06/2011 - 01/2003
3Squamous Cell Carcinoma of Head and Neck
08/2022 - 01/2021
3Mitochondrial Diseases (Mitochondrial Disease)
04/2022 - 07/2008
3B-Cell Lymphoma (Lymphoma, B Cell)
01/2022 - 12/2018

Drug/Important Bio-Agent (IBA)

34Proteins (Proteins, Gene)FDA Link
01/2022 - 12/2004
33Pharmaceutical PreparationsIBA
03/2021 - 08/2003
32Phosphotransferases (Kinase)IBA
01/2022 - 10/2005
19Biomarkers (Surrogate Marker)IBA
08/2022 - 10/2005
16Biological ProductsIBA
01/2022 - 07/2005
14DNA (Deoxyribonucleic Acid)IBA
01/2019 - 10/2005
13salvicineIBA
09/2008 - 12/2002
12Tyrosine (L-Tyrosine)FDA Link
11/2017 - 04/2005
10Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2018 - 12/2004
9MicroRNAs (MicroRNA)IBA
10/2022 - 01/2013
9heparanaseIBA
08/2018 - 10/2005
8ErbB Receptors (EGF Receptor)IBA
12/2022 - 12/2008
8Long Noncoding RNAIBA
01/2021 - 01/2014
7Therapeutic UsesIBA
08/2022 - 12/2005
7CytokinesIBA
01/2022 - 01/2005
7Messenger RNA (mRNA)IBA
12/2021 - 10/2004
7Small Interfering RNA (siRNA)IBA
02/2020 - 04/2007
7Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
02/2017 - 01/2003
7trioctyl phosphine oxide (TOPO)IBA
12/2014 - 02/2007
6RNA (Ribonucleic Acid)IBA
08/2022 - 09/2014
6EnzymesIBA
01/2022 - 08/2015
6Gefitinib (Iressa)FDA Link
01/2022 - 11/2015
6IronIBA
01/2020 - 07/2008
6Type II DNA Topoisomerases (Topoisomerase II)IBA
04/2015 - 08/2003
5Cisplatin (Platino)FDA LinkGeneric
01/2021 - 07/2003
5Antineoplastic Agents (Antineoplastics)IBA
03/2018 - 10/2004
5Doxorubicin (Adriamycin)FDA LinkGeneric
01/2018 - 07/2004
5Epidermal Growth Factor (EGF)IBA
12/2017 - 08/2004
5Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA
11/2017 - 01/2017
5TubulinIBA
07/2014 - 04/2006
5OligosaccharidesIBA
06/2014 - 02/2005
5oligomannurarate sulfateIBA
06/2014 - 09/2006
5TOR Serine-Threonine KinasesIBA
01/2014 - 01/2009
5Fibronectins (Fibronectin)IBA
11/2009 - 05/2005
5Focal Adhesion Protein-Tyrosine KinasesIBA
11/2008 - 04/2005
4AntioxidantsIBA
04/2022 - 08/2015
4osimertinibIBA
02/2022 - 01/2019
4CYH33IBA
01/2022 - 10/2018
4PlasticsIBA
01/2021 - 01/2017
4Angiogenesis InhibitorsIBA
01/2021 - 04/2006
4Hematoxylin (Haematoxylon)IBA
01/2021 - 07/2011
4Sirolimus (Rapamycin)FDA Link
02/2020 - 09/2010
4Adenosine Triphosphate (ATP)IBA
01/2019 - 11/2006
4Matrix Metalloproteinases (MMPs)IBA
01/2019 - 11/2004
4Reactive Oxygen Species (Oxygen Radicals)IBA
01/2019 - 07/2008
4VaccinesIBA
01/2018 - 03/2002
4Tyrosine Kinase InhibitorsIBA
01/2018 - 06/2005
4Polysaccharides (Glycans)IBA
06/2016 - 08/2004
4IntegrinsIBA
08/2015 - 10/2006
4artenimol (dihydroartemisinin)IBA
01/2012 - 07/2008
4Topoisomerase II InhibitorsIBA
08/2011 - 08/2003
4RazoxaneIBA
11/2010 - 12/2004
4Telomerase (Telomerase Reverse Transcriptase)IBA
02/2008 - 12/2002
4GastrinsIBA
01/2008 - 04/2005
3Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA
01/2022 - 11/2014

Therapy/Procedure

88Therapeutics
11/2022 - 08/2003
13Drug Therapy (Chemotherapy)
01/2022 - 01/2006
10Oral Administration
02/2022 - 01/2014
7Electroacupuncture
11/2019 - 02/2014
4Chinese Traditional Medicine (Traditional Chinese Medicine)
01/2019 - 05/2007
3Immunotherapy
01/2022 - 01/2018